| 含马兜铃酸中药的安全性探讨 |
| |
| 引用本文： | 郭晓昕,刘佳,吴晔,任经天,程鲁榕.含马兜铃酸中药的安全性探讨[J].中国药物警戒,2004,1(2):31-33. |
| |
| 作者姓名： | 郭晓昕 刘佳 吴晔 任经天 程鲁榕 |
| |
| 作者单位： | 国家食品药品监督管理局药品评价中心,北京,100061 |
| |
| 摘 要： | 目的 探讨含马兜铃酸中药的安全性,为临床合理用药提供参考.方法 通过检索国内外公开发表的文献和各国官方网站,收集与马兜铃酸有关的不良反应病例,分析其安全性.结果 与马兜铃酸有关的不良反应主要为肾损害,部分病例出现尿道上皮癌.结论 临床应重视含马兜铃酸药物的潜在肾毒性,保障人民用药安全.
|
| 关 键 词： | 马兜铃酸 不良反应 肾损害 |
The exploration of safety of traditional Chinese medicine containing aristolochic acid |
| |
| GUO Xiao-xin,LIU Jia,WU Ye,REN Jing-tian,CHENG Lu-rong.The exploration of safety of traditional Chinese medicine containing aristolochic acid[J].Chinese JOurnal of Pharmacovigilance,2004,1(2):31-33. |
| |
| Authors: | GUO Xiao-xin LIU Jia WU Ye REN Jing-tian CHENG Lu-rong |
| |
| Abstract: | Objective To explore the safety of traditional Chinese medicine (TCM) containing aristolochic acid in order to its rational drug use. Method Searching published literatures and website associated with aristolochic acid toxicities both domestic and abroad and analyzing them. Results The main ADR related to aristolochic acid is nephropathy, urothelial cancer being found on some patients. Conclusion More attentions should be paid on the potential risk of TCM containing aristolochic acid to protect patients. |
| |
| Keywords: | Aristolochic acid ADR Nephropathy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
